This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, D. C. Articles by Arnold, A. Search for Related Content PubMed PubMed Citation Articles by Chung, D. C. Articles by Arnold, A.

Overexpression of Cyclin D1 Occurs Frequently in Human Pancreatic Endocrine Tumors¹

Gastrointestinal Unit and Department of Medicine (D.C.C.), Department of Pathology (F.G.-C.), Department of Surgery (A.L.W.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; Center for Molecular Medicine (S.B.B., A.A.), University of Connecticut Health Center, Farmington, Connecticut 06030; Laboratory of Chemotherapy (M.S.), Aichi Cancer Center, Nagoya, Japan; and Digestive Diseases Branch (R.T.J.), National Institutes of Health, Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Daniel C. Chung, Gastrointestinal Unit, GRJ 825, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114. E-mail: d_chung{at}helix.mgh.harvard.edu

The molecular pathogenesis of human pancreatic endocrine tumors (PETs) is poorly understood. Three independent animal models have pointed to the pivotal role of the G₁/S cell cycle transition in pancreatic endocrine cell proliferation. We thus hypothesized that the cell cycle regulator cyclin D1 may contribute to the pathogenesis of human PETs. Overexpression of cyclin D1 was identified in 43% of cases, and no correlation was observed with clinical phenotype. The novel observation of frequent overexpression of cyclin D1 suggests that this established oncogene may be implicated in the pathogenesis of human PETs. The absence of detectable alterations in cyclin D1 genomic structure suggests that the mechanism for its oncogenic activation in PETs may be transcriptional or posttranscriptional.

This article has been cited by other articles:

				I. Cozar-Castellano, G. Harb, K. Selk, K. Takane, R. Vasavada, B. Sicari, B. Law, P. Zhang, D. K. Scott, N. Fiaschi-Taesch, et al. Lessons From the First Comprehensive Molecular Characterization of Cell Cycle Control in Rodent Insulinoma Cell Lines Diabetes, November 1, 2008; 57(11): 3056 - 3068. [Abstract] [Full Text] [PDF]

				E.-M. Duerr, Y. Mizukami, A. Ng, R. J Xavier, H. Kikuchi, V. Deshpande, A. L Warshaw, J. Glickman, M. H Kulke, and D. C Chung Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis Endocr. Relat. Cancer, March 1, 2008; 15(1): 243 - 256. [Abstract] [Full Text] [PDF]

				S Fontaniere, J Tost, A Wierinckx, J Lachuer, J Lu, N Hussein, F Busato, I Gut, Z-Q Wang, and C-X Zhang Gene expression profiling in insulinomas of Men1 {beta}-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic {beta}-cell tumorigenesis Endocr. Relat. Cancer, December 1, 2006; 13(4): 1223 - 1236. [Abstract] [Full Text] [PDF]

				H.-S. Shiah, W. Gao, D. C. Baker, and Y.-C. Cheng Inhibition of cell growth and nuclear factor-{kappa}B activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503. Mol. Cancer Ther., October 1, 2006; 5(10): 2484 - 2493. [Abstract] [Full Text] [PDF]

				I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell Endocr. Rev., June 1, 2006; 27(4): 356 - 370. [Abstract] [Full Text] [PDF]

				I. Cozar-Castellano, M. Weinstock, M. Haught, S. Velazquez-Garcia, D. Sipula, and A. F. Stewart Evaluation of {beta}-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen: Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip Diabetes, January 1, 2006; 55(1): 70 - 77. [Abstract] [Full Text] [PDF]

				X. Zhang, J. P. Gaspard, Y. Mizukami, J. Li, F. Graeme-Cook, and D. C. Chung Overexpression of Cyclin D1 in Pancreatic {beta}-Cells In Vivo Results in Islet Hyperplasia Without Hypoglycemia Diabetes, March 1, 2005; 54(3): 712 - 719. [Abstract] [Full Text] [PDF]

				I. Cozar-Castellano, K. K. Takane, R. Bottino, A.N. Balamurugan, and A. F. Stewart Induction of {beta}-Cell Proliferation and Retinoblastoma Protein Phosphorylation in Rat and Human Islets Using Adenovirus-Mediated Transfer of Cyclin-Dependent Kinase-4 and Cyclin D1 Diabetes, January 1, 2004; 53(1): 149 - 159. [Abstract] [Full Text] [PDF]